DT.BIOTECH INNOV.AG O.N./ DE000A0Z25L1 /
| 9/19/2024 8:08:52 AM | Chg. 0.000 | Volume | Bid2:00:41 PM | Ask1:53:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.400EUR | 0.00% | 0 Turnover: 0.000 |
1.400Bid Size: 50 | -Ask Size: - | 1.33 mill.EUR | 0.00% | - |
Fundamentals
| FY 2019 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.43 EUR | 144.56% |
| EPS Diluted: | -0.43 EUR | 144.56% |
| Revenues per Share: | 0.00 EUR | - |
| Book Value per Share: | 1.58 EUR | -21.05% |
| Cash Flow per Share: | -0.84 EUR | 700.00% |
| Dividend per Share: | 0.00 EUR | - |
| Total | in mill. | |
| Revenues: | 0.00 EUR | -100.00% |
| Net Income: | -0.40 EUR | 100.00% |
| Operating Cash Flow: | -0.80 EUR | - |
| Cash and Cash Equivalents: | 0.10 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | - | - |
| P/BV ratio: | 0.88 | 40.72 |
| P/CF Ratio: | -1.66 | -76.35 |
| PEG: | -0.02 | - |
| Earnings Yield: | -30.50% | -0.66% |
| Dividend Yield: | 0.00% | 0.00% |
| Market Capitalization | ||
| Market Capitalization: | 1.33 mill. EUR | 61.08 mill. EUR |
| Free Float Market Cap.: | 49,054.6000 EUR | 2.26 mill. EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 947,000 | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | - |
| Net Profit Margin: | - |
| Return on Equity: | -26.67% |
| Return on Assets: | -20.00% |
Financial Strength
| Liquidity I / Cash Ratio: | - |
| Liquidity II / Quick Ratio: | - |
| Liquidity III / Current Ratio: | - |
| Debt / Equity Ratio: | 33.33% |
| Dynam. Debt / Equity Ratio: | -62.50% |
Efficiency
| Employees: | 0 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 12/31/2019 |
| Accounting Standard: | HGB |
| Currency: | EUR |
